HCA Healthcare, Inc.
HCA Healthcare, Inc. (HCA) Stock News
The latest HCA headlines and market coverage — 6 recent stories, updated throughout the day.
- Zacks Investment Research·
Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA Healthcare is leveraging its multi-year resiliency program focused on digital transformation and shared services to control unit costs and maintain profitability despite facing a $1.0-$1.2 billion headwind from health insurance exchange disenrollment in 2026. The company achieved flat year-over-year cost per admission in Q2 and targets 4-6% long-term adjusted EBITDA growth. Peers Tenet Healthcare and Universal Health Services are similarly pursuing operational efficiency initiatives.
- GlobeNewswire Inc.·
HCA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating HCA Healthcare, Inc. on Behalf of HCA Stockholders and Encourages Investors to Contact the Firm
Law firm Bragar Eagel & Squire is investigating HCA Healthcare for potential federal securities law violations following the company's July 14, 2026 announcement of sharply lowered full-year profit guidance due to unfavorable payer mix changes impacting revenue by approximately $400 million. HCA's stock fell 6.95% ($27.14 per share) to $363.60 on the news. The firm is seeking stockholders who suffered losses to participate in the action.
- GlobeNewswire Inc.·
GE HEALTHCARE STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating GE HealthCare Technologies Inc. on Behalf of GE HealthCare Stockholders and Encourages Investors to Contact the Firm
Law firm Bragar Eagel & Squire is investigating GE HealthCare Technologies for potential securities law violations following the company's April 29, 2026 earnings announcement. GE HealthCare missed Q1 2026 consensus EPS estimates ($0.99 vs. $1.05 expected) and reduced full-year guidance to $4.80-$5.00 from $4.95-$5.15, citing a PDx supplier issue. The stock declined 13% ($9.01 per share) on the news.
- Seeking Alpha·Neutral
HCA projects 2% to 3% volume growth while holding 2026 outlook amid $600M to $900M exchange headwind
- Benzinga·Bearish
Hospital Operator HCA Healthcare Flags Soft Respiratory Season As Volumes Lag
HCA Healthcare reported Q1 2026 earnings of $7.15 per share, in line with consensus, but shares fell 9.08% due to weak volume metrics. The company experienced a soft respiratory season with respiratory admissions down 42% and ER visits down 32% year-over-year, along with winter storm impacts. Despite reaffirming 2026 guidance, same-facility metrics showed mixed trends with modest admission growth
- Seeking Alpha·Neutral
HCA Healthcare declares $0.78 dividend